WASHINGTON, D.C. – Susan Monarez was confirmed as director of the U.S. Centers for Disease Control and Prevention (CDC) by the Senate on July 29, 2025, with a vote of 51-47.
Monarez, 50, becomes the first CDC director to undergo Senate confirmation under a 2023 law requiring such approval. She previously served as acting director since January.
Her nomination followed the withdrawal of David Weldon, the original nominee, by President Donald Trump in March.
Monarez holds a doctorate in microbiology and immunology and has extensive experience in health technology and biosecurity prior to joining the CDC.
The agency has faced challenges including staff reductions and debates over vaccine protocols amid shifting public health policies.
Monarez stepped down as acting director in March to facilitate the confirmation process.
Her appointment aims to provide leadership stability as the CDC addresses ongoing public health concerns and adapts to new legislative requirements.
The Senate confirmation highlights the emphasis on scientific expertise and experience in health technology for the agency’s leadership.
Monarez’s role includes managing public health responses and collaborating with governmental and health organizations to enhance national health security.
The CDC continues its mission to safeguard public health with renewed leadership under Monarez.